<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998110</article-id><article-id pub-id-type="pmc">PMC11860916</article-id>
<article-id pub-id-type="doi">10.3390/toxins17020093</article-id><article-id pub-id-type="publisher-id">toxins-17-00093</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>ConoGPT: Fine-Tuning a Protein Language Model by Incorporating Disulfide Bond Information for Conotoxin Sequence Generation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Guohui</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00093" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4010-5686</contrib-id><name><surname>Ge</surname><given-names>Cheng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af2-toxins-17-00093" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Wenzheng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-toxins-17-00093" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6625-2014</contrib-id><name><surname>Yu</surname><given-names>Rilei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af2-toxins-17-00093" ref-type="aff">2</xref><xref rid="c1-toxins-17-00093" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6572-3408</contrib-id><name><surname>Liu</surname><given-names>Hao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-toxins-17-00093" ref-type="aff">1</xref><xref rid="c1-toxins-17-00093" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-toxins-17-00093"><label>1</label>College of Computer Science and Technology, Ocean University of China, Songling Road, Qingdao 266100, China; <email>zhaoguohui@stu.ouc.edu.cn</email> (G.Z.); <email>hanwenzheng@stu.ouc.edu.cn</email> (W.H.)</aff><aff id="af2-toxins-17-00093"><label>2</label>School of Medicine and Pharmacy, Ocean University of China, Songling Road, Qingdao 266100, China</aff><author-notes><corresp id="c1-toxins-17-00093"><label>*</label>Correspondence: <email>ryu@ouc.edu.cn</email> (R.Y.); <email>liu.hao@ouc.edu.cn</email> (H.L.)</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>93</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>26</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Conotoxins are a class of peptide toxins secreted by marine mollusks of the Conus genus, characterized by their unique mechanism of action and significant biological activity, making them highly valuable for drug development. However, traditional methods of acquiring conotoxins, such as in vivo extraction or chemical synthesis, face challenges of high costs, long cycles, and limited exploration of sequence diversity. To address these issues, we propose the ConoGPT model, a conotoxin sequence generation model that fine-tunes the ProtGPT2 model by incorporating disulfide bond information. Experimental results demonstrate that sequences generated by ConoGPT exhibit high consistency with authentic conotoxins in physicochemical properties and show considerable potential for generating novel conotoxins. Furthermore, compared to models without disulfide bond information, ConoGPT outperforms in terms of generating sequences with ordered structures. The majority of the filtered sequences were shown to possess significant binding affinities to nicotinic acetylcholine receptor (nAChR) targets based on molecular docking. Molecular dynamics simulations of the selected sequences further confirmed the dynamic stability of the generated sequences in complex with their respective targets. This study not only provides a new technological approach for conotoxin design but also offers a novel strategy for generating functional peptides.</p></abstract><kwd-group><kwd>conotoxins</kwd><kwd>protein language model</kwd><kwd>peptide generation</kwd><kwd>activity prediction</kwd><kwd>receptors</kwd></kwd-group><funding-group><award-group><funding-source>Key R&#x00026;D Program of Shandong Province</funding-source><award-id>2023CXPT020</award-id></award-group><funding-statement>This work is supported by the Key R&#x00026;D Program of Shandong Province, China (No. 2023CXPT020).</funding-statement></funding-group></article-meta><notes notes-type="Key Contribution"><title>Key Contribution</title><p>Incorporating disulfide bond information into protein language model fine-tuning generates valid conotoxins with ordered structures and potential bioactivity.</p></notes></front><body><sec sec-type="intro" id="sec1-toxins-17-00093"><title>1. Introduction</title><p>Conotoxins are a class of peptide toxins secreted by marine mollusks of the genus Conus. These peptides are rich in disulfide bonds and exhibit highly specific mechanisms of action, targeting acetylcholine receptors, subtypes of other neurotransmitter receptors, as well as sodium, potassium, and calcium ion channels. Their high specificity and unique mechanisms make conotoxins attractive candidates for therapeutic applications [<xref rid="B1-toxins-17-00093" ref-type="bibr">1</xref>,<xref rid="B2-toxins-17-00093" ref-type="bibr">2</xref>]. For instance, the drug Ziconotide, derived from conotoxins, has been approved for treating severe chronic pain [<xref rid="B3-toxins-17-00093" ref-type="bibr">3</xref>]. Due to their remarkable bioactivity and potential pharmaceutical value, conotoxins are a major focus in protein engineering and drug discovery. However, traditional methods of obtaining conotoxins, such as extraction from natural sources [<xref rid="B4-toxins-17-00093" ref-type="bibr">4</xref>,<xref rid="B5-toxins-17-00093" ref-type="bibr">5</xref>] or chemical synthesis [<xref rid="B6-toxins-17-00093" ref-type="bibr">6</xref>], are costly, time-consuming, and limit the exploration of the vast sequence diversity of conotoxins. Consequently, there is an urgent need for advanced deep learning approaches to efficiently discover and generate bioactive conotoxins.</p><p>In recent years, the development of generative artificial intelligence has revolutionized the design of drugs [<xref rid="B7-toxins-17-00093" ref-type="bibr">7</xref>], proteins [<xref rid="B8-toxins-17-00093" ref-type="bibr">8</xref>], and peptides [<xref rid="B9-toxins-17-00093" ref-type="bibr">9</xref>,<xref rid="B10-toxins-17-00093" ref-type="bibr">10</xref>,<xref rid="B11-toxins-17-00093" ref-type="bibr">11</xref>]. In the field of peptide generation, the most widely used frameworks include generative adversarial networks (GANs) [<xref rid="B12-toxins-17-00093" ref-type="bibr">12</xref>,<xref rid="B13-toxins-17-00093" ref-type="bibr">13</xref>,<xref rid="B14-toxins-17-00093" ref-type="bibr">14</xref>], variational autoencoders (VAEs) [<xref rid="B15-toxins-17-00093" ref-type="bibr">15</xref>,<xref rid="B16-toxins-17-00093" ref-type="bibr">16</xref>,<xref rid="B17-toxins-17-00093" ref-type="bibr">17</xref>], and diffusion models [<xref rid="B18-toxins-17-00093" ref-type="bibr">18</xref>].</p><p>GANs, particularly bidirectional conditional GANs (BiCGANs) [<xref rid="B13-toxins-17-00093" ref-type="bibr">13</xref>], have shown promise in addressing the unique challenges of designing antimicrobial peptides by mapping peptide sequences into the latent space of the generator. However, GANs are prone to mode collapse, leading to reduced diversity in generated molecules, and their training process is often unstable and difficult to optimize. VAEs, especially their conditional variants (cVAEs), are also at the forefront of peptide generation research. While VAEs probabilistically map input peptide data into a latent space, cVAEs enhance specificity and controllability in peptide generation by incorporating conditional information. Studies have demonstrated the ability of modified cVAEs to generate peptides with desirable properties, particularly in the context of antimicrobial peptide design [<xref rid="B19-toxins-17-00093" ref-type="bibr">19</xref>]. However, the reliability of cVAE-generated sequences remains a challenge. Recent studies utilizing diffusion models have demonstrated their potential to generate antimicrobial peptides [<xref rid="B18-toxins-17-00093" ref-type="bibr">18</xref>]. Although diffusion models excel in generating complex sequences, their high computational cost, slower generation speed, and sensitivity to model parameters limit their broader application.</p><p>In contrast, protein language models trained on large-scale protein databases capture deep patterns and structural information within protein sequences, enabling the generation of diverse, high-quality sequences. Recent advances have explored the use of large language models for protein design. ProGEN [<xref rid="B20-toxins-17-00093" ref-type="bibr">20</xref>], for example, employs a 1.2B parameter language model to controllably generate proteins with specified molecular functions or cellular components. ProtGPT2 [<xref rid="B21-toxins-17-00093" ref-type="bibr">21</xref>], a GPT2-based language model, has been trained on protein sequence space to generate novel proteins adhering to natural protein principles. Furthermore, fine-tuning pre-trained language models on specific datasets has been successfully applied in tasks such as enzyme design [<xref rid="B22-toxins-17-00093" ref-type="bibr">22</xref>] and post-translational modification prediction [<xref rid="B23-toxins-17-00093" ref-type="bibr">23</xref>], making them ideal for conotoxin generation.</p><p>Mature conotoxins typically contain multiple disulfide bonds, which are critical for their structural stability and functional activity [<xref rid="B24-toxins-17-00093" ref-type="bibr">24</xref>]. Disulfide bonds not only maintain the three-dimensional structure of conotoxins but also directly influence their binding specificity and bioactivity toward target receptors. Therefore, incorporating disulfide bond information in conotoxin generation tasks is essential for capturing their key structural characteristics.</p><p>To address these challenges, we propose ConoGPT, a conotoxin generation model that fine-tunes ProtGPT2 with disulfide bond information to generate bioactive and structurally ordered conotoxin sequences. By introducing disulfide bond annotations in the training data, our approach aims to investigate the potential influence of disulfide information on sequence generation. This strategy enables the model to better capture the critical structural features of conotoxins. Experimental results demonstrate that the generated sequences exhibit high consistency in physicochemical properties compared to natural conotoxins and perform well in structural prediction, activity evaluation, and molecular docking experiments. This study provides an efficient and reliable method for the generation and optimization of conotoxin sequences, advancing their application in drug development and offering new directions for generating other functional protein sequences.</p></sec><sec sec-type="results" id="sec2-toxins-17-00093"><title>2. Results</title><sec id="sec2dot1-toxins-17-00093"><title>2.1. Comparison of Generated Sequences with Real Conotoxin Sequences</title><p>To assess the biological plausibility and effectiveness of the sequences generated by the ConoGPT model, 10,000 sequences were randomly generated and compared across multiple dimensions with known real conotoxin sequences, primarily sourced from the ConoServer database [<xref rid="B25-toxins-17-00093" ref-type="bibr">25</xref>]. The analyses encompassed amino acid composition, physicochemical properties, Shannon Entropy of subsequence distributions, cysteine framework distributions, and sequence similarity scores.</p><sec id="sec2dot1dot1-toxins-17-00093"><title>2.1.1. Amino Acid Composition and Physicochemical Properties</title><p>The amino acid composition analysis (<xref rid="toxins-17-00093-f001" ref-type="fig">Figure 1</xref>a) revealed that the generated sequences closely resemble the real conotoxins, especially in the proportions of key amino acids such as cysteine(C) and glutamic acid(E), which play critical roles in conotoxin structure and function [<xref rid="B26-toxins-17-00093" ref-type="bibr">26</xref>]. For charge distribution (<xref rid="toxins-17-00093-f001" ref-type="fig">Figure 1</xref>b), both the generated and real sequences exhibited similar profiles, with the majority of sequences having a charge between 0 and +3. This overlap indicates that the generated sequences possess charge properties comparable to real conotoxins. However, the generated sequences show a slightly higher proportion at zero charge, which may be attributable to a bias toward neutral charges in the model itself. Isoelectric point (pI) analysis (<xref rid="toxins-17-00093-f001" ref-type="fig">Figure 1</xref>c) showed that both groups had overlapping distributions in the range of 4 to 10, with a peak at 6&#x02013;8, further confirming the reasonable physicochemical properties of the generated sequences. Lastly, we computed the hydrophobicity scores of both the generated and real conotoxins using the Kyte&#x02013;Doolittle hydropathy index. The hydrophobicity distributions (<xref rid="toxins-17-00093-f001" ref-type="fig">Figure 1</xref>d) demonstrated a high degree of similarity, with both groups centered near zero, a property critical for the stability and functionality of conotoxins. Collectively, these results underscore the ability of the ConoGPT model to capture the essential features of real conotoxins in its generated sequences.</p></sec><sec id="sec2dot1dot2-toxins-17-00093"><title>2.1.2. Shannon Entropy of Subsequence Distribution</title><p>Shannon Entropy [<xref rid="B27-toxins-17-00093" ref-type="bibr">27</xref>] is a measure from information theory used to quantify the diversity or uncertainty of a distribution. We evaluate the subsequence distribution of generated and real sequences by calculating their Shannon Entropy. In <xref rid="toxins-17-00093-f002" ref-type="fig">Figure 2</xref>, we provide word shifts between generated and real conotoxin sequences for subsequences of lengths 2 and 3. The subsequences more common in the generated peptides predominantly involve one or more instances of cysteine (C) or glycine (G). Conversely, subsequences enriched in real peptides are more likely to involve glutamic acid (E) or alanine (A). These compositional differences reflect unique sequence preferences between the two groups.</p><p>The preference for C and G in the generated sequences aligns with structural features such as disulfide bond formation (C) and increased flexibility (G). Meanwhile, the enrichment of E and A in real sequences suggests contributions to negative charge properties (E) and the formation of hydrophobic cores (A).</p></sec><sec id="sec2dot1dot3-toxins-17-00093"><title>2.1.3. Cysteine Framework Distribution Analysis</title><p>Cysteine frameworks are critical features of conotoxins, as they determine the spatial conformation and functional stability of the peptides. As shown in <xref rid="toxins-17-00093-f003" ref-type="fig">Figure 3</xref>, there are notable differences in the framework distributions between the generated and real sequences. In real conotoxin sequences, the predominant frameworks are type I (CC-C-C) and VI/VII (C-C-CC-C-C), accounting for 29.5% and 26.3% of the distribution, respectively. In contrast, the proportion of type I frameworks in the generated sequences is 21.1%, while the VI/VII frameworks show a significant reduction, accounting for only 3.2%. Additionally, the generated sequences exhibit a higher proportion of type XVI (C-C-CC) frameworks (9.1%) and type XIV (C-C-C-C) frameworks (5.5%), which are relatively less frequent in the real sequences. This may suggest that the model prefers to generate sequences containing two disulfide bonds.</p><p>Notably, 52.7% of the generated sequences may contain previously undiscovered types of cysteine frameworks, suggesting the potential for developing novel conotoxins with a new structure.</p></sec><sec id="sec2dot1dot4-toxins-17-00093"><title>2.1.4. Diversity Analysis</title><p>When proposing candidate conotoxins, it is important that the generated candidates are diverse as a population and novel relative to known conotoxins. As shown in <xref rid="toxins-17-00093-f004" ref-type="fig">Figure 4</xref>, we analyzed the distribution of sequence match scores across three groups: &#x0201c;Real vs. Self&#x0201d;, &#x0201c;Generated vs. Self&#x0201d;, and &#x0201c;Generated vs. Real&#x0201d;. Match scores were calculated using global sequence alignment based on the BLOSUM62 [<xref rid="B28-toxins-17-00093" ref-type="bibr">28</xref>] substitution matrix. The &#x0201c;Real vs. Self&#x0201d; group exhibited a high median match score (~150) with a relatively narrow distribution, indicating strong internal consistency among real conotoxin sequences. The symmetric distribution and a small number of outliers further suggest limited sequence variability within the real conotoxin dataset. In contrast, the &#x0201c;Generated vs. Self&#x0201d; group displayed a broader and more dispersed distribution with a lower median match score (~100), reflecting greater diversity among the generated sequences compared to the real conotoxins. Additionally, some outliers with high match scores indicate that certain generated sequences are highly similar to others within the generated dataset. The &#x0201c;Generated vs. Real&#x0201d; group exhibited the lowest median match score (~50) and a narrower distribution skewed toward lower match scores. This highlights the substantial differences between generated and real conotoxin sequences, underscoring the novelty and uniqueness of the generated sequences.</p></sec><sec id="sec2dot1dot5-toxins-17-00093"><title>2.1.5. Activity Assessment</title><p>In order to evaluate the potential biological functionality of the generated sequences, we employed a publicly available peptide activity prediction framework, UniDL4BioPep [<xref rid="B29-toxins-17-00093" ref-type="bibr">29</xref>], which was retrained specifically for a binary classification task tailored to conotoxins. The model predicted that 81.86% of the generated sequences are likely to be bioactive, indicating that the fine-tuned model incorporating disulfide bond information performs well in terms of generating sequences with potential activity. To provide a more intuitive representation of the feature distribution of generated and real sequences in the embedding space, we used UMAP [<xref rid="B30-toxins-17-00093" ref-type="bibr">30</xref>] to visualize the high-dimensional embeddings in reduced dimensions, as shown in <xref rid="toxins-17-00093-f005" ref-type="fig">Figure 5</xref>. In the UMAP plot, the majority of generated sequences (mint green) cluster within the regions occupied by real active sequences (red), demonstrating high similarity between the generated sequences and real active sequences in the embedding space. Meanwhile, some generated sequences extend into new regions of the embedding space, suggesting that the model possesses innovation capabilities and can explore potential sequence features not present in the training dataset.</p></sec></sec><sec id="sec2dot2-toxins-17-00093"><title>2.2. Comparative Analysis of Model Performance</title><p>To further investigate the impact of incorporating disulfide bond information on the performance of the generation model, we compared the properties of sequences generated by the baseline model (without disulfide bond information) and the improved model (with disulfide bond information). The analysis focused on four key aspects: perplexity, structural order (measured by pLDDT values), cysteine framework distribution, and activity prediction outcomes. These comparisons comprehensively evaluate the influence of disulfide bond information on the characteristics of the generated sequences.</p><sec id="sec2dot2dot1-toxins-17-00093"><title>2.2.1. Perplexity Comparison</title><p>Perplexity is a crucial metric for evaluating the predictive capability of language models, reflecting the model&#x02019;s confidence in sequence generation. Lower perplexity generally indicates that the generated sequences better align with the distribution of the training data. <xref rid="toxins-17-00093-f006" ref-type="fig">Figure 6</xref> compares the perplexity distributions of sequences generated by the baseline model (without disulfide bond information) and the improved model (with disulfide bond information). The improved model demonstrates a slightly lower average perplexity (79.79) compared to the baseline model (81.83). This marginal improvement suggests that the inclusion of disulfide bond information helps the model better capture the structural and sequential characteristics of conotoxins. The perplexity density curves of both models, however, exhibit significant overlap, indicating similar predictive capabilities. Notably, the perplexity distributions for both models are concentrated within the range of 50 to 150, with the improved model showing a slightly higher density around lower perplexity values.</p></sec><sec id="sec2dot2dot2-toxins-17-00093"><title>2.2.2. Evaluation of Structural Orderliness in Generated Sequences</title><p>An essential characteristic to consider when designing conotoxin sequences is their ability to fold into stable and ordered structures. We employed ESMFold [<xref rid="B31-toxins-17-00093" ref-type="bibr">31</xref>] to predict the three-dimensional structures of the generated sequences and calculated the pLDDT score for each sequence. A pLDDT score between 70 and 90 indicates a well-modeled, ordered structure, while lower scores (pLDDT &#x0003c; 50) are typically associated with disordered regions [<xref rid="B32-toxins-17-00093" ref-type="bibr">32</xref>].</p><p>To ensure the quality of the generated sequences and the validity of subsequent analyses, the top 1000 sequences with the lowest perplexity were selected from the 10,000 sequences generated by each model. By averaging the results of five independent generation trials, we minimized experimental randomness and ensured robust conclusions. Using box plots, we visually compared the pLDDT distribution characteristics of the two models, and the proportion of high-confidence sequences (pLDDT &#x0003e; 0.7) was also calculated.</p><p>Below, <xref rid="toxins-17-00093-f007" ref-type="fig">Figure 7</xref> presents the box plot comparison of pLDDT distributions, and <xref rid="toxins-17-00093-t001" ref-type="table">Table 1</xref> summarizes the proportion of high-confidence sequences for both models.</p></sec><sec id="sec2dot2dot3-toxins-17-00093"><title>2.2.3. Evaluation of Cysteine Framework Distributions</title><p>The cysteine framework of conotoxins is closely related to their disulfide connectivity, which forms the basis for the improved model&#x02019;s integration of disulfide bond information. To assess the influence of this improvement, we compared the distribution of known cysteine frameworks between the improved model and the baseline model, with the results shown in <xref rid="toxins-17-00093-f008" ref-type="fig">Figure 8</xref>.</p></sec><sec id="sec2dot2dot4-toxins-17-00093"><title>2.2.4. Analysis of Activity Prediction</title><p>To further evaluate the potential bioactivity of the generated sequences, we employed a retrained UniDL4BioPep activity prediction model to assess sequences generated by the two models. UniDL4BioPep, a framework specifically designed for peptide activity prediction, was retrained in this study for a binary classification task tailored to conotoxins.</p><p>The results revealed that 81.86% of the sequences generated by the improved model were predicted to be bioactive, compared to 80.26% for the baseline model. The slight difference in bioactive proportions indicates that incorporating disulfide bond information in the fine-tuning process has a minimal impact on the bioactivity potential of the generated sequences.</p></sec></sec><sec id="sec2dot3-toxins-17-00093"><title>2.3. Functional Validation of Generated Sequences</title><p>Functional validation is a critical step in assessing the potential applicability of the generated conotoxin sequences. Beyond evaluating the physicochemical properties and structural stability of these sequences, it is essential to determine their ability to interact with biological targets effectively. In this study, we focused on two key validation strategies: molecular docking and molecular dynamics simulations. These methods provide insights into the binding affinities and dynamic stability of the generated sequences with relevant receptor targets, offering a comprehensive evaluation of their potential biological functions and applications.</p><sec id="sec2dot3dot1-toxins-17-00093"><title>2.3.1. Analysis of Molecular Docking</title><p>To evaluate the functional potential of the sequences generated by the improved model, we conducted molecular docking analysis on 191 high-quality sequences obtained through multiple selection steps. These sequences were derived from 10,000 randomly generated sequences and underwent filtering based on perplexity (top 1000), structural stability assessment (pLDDT &#x0003e; 0.7), and activity prediction. The three-dimensional structures of the sequences were predicted using AlphaFold3, which ensures a reliable structural basis for subsequent docking analyses. The docking targets included common subtypes of nicotinic acetylcholine receptors (nAChRs), sodium channels (Na), calcium channels (Ca), and potassium channels (K). The docking scores obtained from LeDock [<xref rid="B33-toxins-17-00093" ref-type="bibr">33</xref>] were used to determine the final targets. Sequences with docking scores below &#x02212;8.0 kcal/mol, and with the lowest docking score among all subtypes of a given target, were assigned to that specific target.</p><p><xref rid="toxins-17-00093-f009" ref-type="fig">Figure 9</xref>a shows the molecular docking result of the generated sequence YRRECCSNPACRVDHPEICG with the &#x003b1;9&#x003b1;10 subtype of nAChR, illustrating its binding interactions and conformational fit within the receptor&#x02019;s binding pocket. <xref rid="toxins-17-00093-f009" ref-type="fig">Figure 9</xref>b presents the docking result of a real conotoxin with the &#x003b1;9&#x003b1;10 subtype of nAChR, showing that both the generated sequence and the real conotoxin bind to the same receptor pocket, further validating the accuracy of the generated sequence&#x02019;s binding mode. <xref rid="toxins-17-00093-f009" ref-type="fig">Figure 9</xref>c presents the docking result of CKGKGAKCSLTSSNCCSGSCRSGKC with a calcium ion channel. <xref rid="toxins-17-00093-f009" ref-type="fig">Figure 9</xref>d shows the docking result of a real conotoxin with the same calcium ion channel, where the binding pose of the real conotoxin differs from the generated sequence, indicating that the generated sequence binds to a different region of the channel compared to the real conotoxin.</p><p>Nicotinic acetylcholine receptors (nAChRs), as classic targets of conotoxins, exhibited a significant binding preference in this study, as shown in <xref rid="toxins-17-00093-t002" ref-type="table">Table 2</xref>. The majority of the generated sequences (90.57%) demonstrated strong binding affinities with nAChRs. This may be because the majority of sequences selected after filtering have cysteine connectivity patterns of C1~C3 and C2~C4, which are typical pairings for &#x003b1;-conotoxins and &#x003b1;-conotoxins target nAChRs [<xref rid="B34-toxins-17-00093" ref-type="bibr">34</xref>].</p></sec><sec id="sec2dot3dot2-toxins-17-00093"><title>2.3.2. Analysis of Molecular Dynamics Simulation</title><p>To further validate the functionality of the generated sequences, molecular dynamics (MDs) simulations were performed for selected sequences and their corresponding targets. <xref rid="toxins-17-00093-f010" ref-type="fig">Figure 10</xref> presents the MDs simulation results for the generated sequence GCCADPKCAFNNPELC in complex with the &#x003b1;3&#x003b2;4 subtype of nAChR.</p><p>During the 100 ns simulation, the radius of gyration (Rg) values stabilized between 2.009 and 2.105 nm, with a final value of 2.057 nm at 100 ns, indicating that the protein structure remained compact. The root-mean-square deviation (RMSD) values fluctuated slightly in the first 20 ns but stabilized over time, suggesting that the system reached equilibrium.</p><p>Binding free energy analysis showed a total binding free energy of &#x02212;19.45 &#x000b1; 8.2 kcal/mol, confirming strong interactions between the protein and peptide. Residue interaction analysis revealed key contributions from protein residues TRP57, ARG59, and ARG81, highlighting their critical role in binding stability. Aromatic residues (such as TRP) and positively charged residues (such as ARG) often play critical roles in protein&#x02013;ligand interactions [<xref rid="B35-toxins-17-00093" ref-type="bibr">35</xref>,<xref rid="B36-toxins-17-00093" ref-type="bibr">36</xref>,<xref rid="B37-toxins-17-00093" ref-type="bibr">37</xref>]. We hypothesize that these residues may contribute to binding stability through different interaction mechanisms. For instance, TRP57 may stabilize the protein&#x02013;peptide complex through hydrophobic interactions, while ARG59 and ARG81 may further enhance binding stability through electrostatic interactions and hydrogen bond formation.</p></sec></sec></sec><sec sec-type="discussion" id="sec3-toxins-17-00093"><title>3. Discussion</title><p>This study presents ConoGPT, a conotoxin generation model fine-tuned with disulfide bond information based on the ProtGPT2 framework. Through comprehensive evaluations of physicochemical properties, structural stability, and functional potential, the effectiveness of this model in generating high-quality and functional conotoxin sequences has been validated.</p><p>We have demonstrated that the sequences generated by ConoGPT exhibit high consistency with real conotoxins in terms of physicochemical properties, including amino acid composition, charge distribution, isoelectric point, and hydrophobicity. This consistency indicates that the fine-tuned model effectively captures the core features of the training data. Diversity analysis further revealed that the generated sequences display considerable diversity, highlighting the potential for discovering novel conotoxins.</p><p>From a functional perspective, the molecular docking results show a remarkable target preference of the generated sequences for nicotinic acetylcholine receptors (nAChRs). Molecular dynamics simulations, conducted on a subset of sequences, further corroborated the structural stability and target binding capabilities of these specific examples. Despite these promising results, certain limitations should be acknowledged. The current study relies on in silico evaluations without experimental validation, and the functional potential of the generated sequences remains theoretical.</p></sec><sec id="sec4-toxins-17-00093"><title>4. Materials and Methods</title><sec id="sec4dot1-toxins-17-00093"><title>4.1. Data Collection and Preprocessing</title><p>The conotoxin sequence data used in this study were sourced from the ConoServer and UniProt databases [<xref rid="B38-toxins-17-00093" ref-type="bibr">38</xref>], focusing on mature peptide sequences with lengths ranging from 10 to 40 amino acids. Specifically, 3289 conotoxin sequences were extracted from the ConoServer database, while an additional 286 sequences were obtained from the UniProt database, resulting in a total dataset of 3525 conotoxin sequences.</p><p>The ConoServer database identifies 31 known cysteine frameworks, of which eight (I, IV, V, VI/VII, IX, X, XI, and XIV) have established disulfide connectivity [<xref rid="B34-toxins-17-00093" ref-type="bibr">34</xref>]. These eight frameworks, along with their cysteine patterns, cysteine counts, disulfide connectivity, and their proportions in the dataset, are detailed in <xref rid="toxins-17-00093-t003" ref-type="table">Table 3</xref>.</p><p>Disulfide pairing annotations based on these frameworks were added at the beginning of each sequence to specify cysteine connectivity, such as [C1&#x02013;C4; C2&#x02013;C3]. This annotation indicates that the first and fourth cysteines in the sequence form a disulfide bond, as do the second and third cysteines. These annotations provided the model with key structural information specific to conotoxin sequences. The remaining sequences, without annotations, were retained to enable the model to learn general features of conotoxins and ensure diversity in the generated sequences.</p><p>Additionally, a negative dataset was collected from the UniProt database for training the UniDL4BioPep classification model. Entries were limited to peptides with a maximum length of 40 amino acids. Any entries containing the keywords &#x0201c;toxic&#x0201d; or &#x0201c;conus&#x0201d; were excluded to avoid overlap with conotoxin-related sequences.</p></sec><sec id="sec4dot2-toxins-17-00093"><title>4.2. Generation Model</title><p>This study employs ProtGPT2 as the foundational model for generating conotoxin sequences. ProtGPT2, a GPT-2-based autoregressive language model, demonstrates robust capabilities in protein sequence generation. The model architecture is based on the GPT2-large Transformer, comprising 36 layers, a model dimensionality of 1280, and 20 multi-head attention units, each with a head dimension of 64, resulting in a total of 738 million parameters. To explore the potential impact of disulfide bond annotations on the generated sequences, this study incorporates such annotations as prefixes in the training data. Although these annotations exist only as prefixes to the input sequences, they provide prior guidance through the model&#x02019;s attention mechanism and contextual learning capabilities. This enables the model to learn implicit relationships between disulfide bonds and sequence features, aiding in the generation of more structurally ordered conotoxin sequences.</p><p>The training objective minimizes the cross-entropy loss, defined as follows:<disp-formula id="FD1-toxins-17-00093"><label>(1)</label><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mrow><mml:munderover><mml:mo stretchy="true">&#x02211;</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mo>&#x000a0;</mml:mo></mml:mrow></mml:mrow><mml:mi>log</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>p</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02223;</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0003c;</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm2" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> represents the <italic toggle="yes">t</italic>&#x02212;th token in the generated sequence, and <inline-formula><mml:math id="mm3" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0003c;</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> denotes the context sequence comprising the preceding <italic toggle="yes">t</italic>&#x02212;1 tokens. Disulfide bond annotations, included as part of the input sequence, are learned alongside subsequent tokens. Through contextual dependencies, the model establishes implicit associations between the annotations and the sequence. The fine-tuning process was conducted on two NVIDIA A6000 GPUs.</p><p>After fine-tuning the model, random sampling is employed to generate candidate conotoxin sequences. To balance the diversity and quality of the generated sequences, several key parameters are configured. The repetition penalty is set to 1.2 to mitigate token repetition during generation. The Top-k parameter is set to 950, restricting sampling at each step to the top 950 tokens with the highest probabilities. These parameter settings have been shown to achieve an optimal balance between diversity and quality in the generated sequences.</p></sec><sec id="sec4dot3-toxins-17-00093"><title>4.3. pLDDT Prediction</title><p>To evaluate the potential structural properties of the generated conotoxin sequences, we employed ESMFold, a highly efficient protein structure prediction tool that leverages protein language models to rapidly generate three-dimensional structures for target sequences. The pLDDT score serves as a proxy for structural orderliness, representing the Predicted Local Distance Difference Test. It corresponds to the model&#x02019;s predicted score on the IDDT-C&#x003b1; metric. A pLDDT score between 70 and 90 indicates a well-modeled, ordered structure, while lower scores (pLDDT &#x0003c; 50) are typically associated with disordered regions.</p></sec><sec id="sec4dot4-toxins-17-00093"><title>4.4. Activity Prediction</title><p>To evaluate the potential biological activity of the generated sequences, we employed the UniDL4BioPep model based on ESM-2 embedding features for activity prediction. UniDL4BioPep is a binary classification model specifically designed to effectively distinguish between bioactive and non-bioactive sequences. For this study, the model was retrained to suit the conotoxin activity prediction task. The training data comprised active sequences extracted from real conotoxin sequences and artificially generated inactive sequences. The dataset was split into training and testing sets at an 8:2 ratio to ensure both model effectiveness and generalization capability.</p><p>The model utilized a convolutional neural network (CNN) architecture as the core of the classification model. It consisted of two one-dimensional convolutional layers, pooling layers, fully connected layers, and a softmax output layer. The convolutional layers captured local patterns within the embedding features, the pooling layers reduced dimensionality to decrease computational complexity, and the fully connected layers integrated global features for final classification. The model&#x02019;s performance was assessed through 10-fold cross-validation, with metrics including accuracy (ACC), balanced accuracy (BACC), sensitivity (Sn), specificity (Sp), Matthews correlation coefficient (MCC), and area under the curve (AUC). The results are presented in <xref rid="toxins-17-00093-t004" ref-type="table">Table 4</xref>.</p></sec><sec id="sec4dot5-toxins-17-00093"><title>4.5. Molecular Docking</title><p>To validate the potential functionality of the generated sequences, molecular docking experiments were conducted using LeDock software (Linux_x86_64 version). LeDock is a highly efficient molecular docking tool capable of rapidly predicting binding modes and binding free energies between molecules and their targets. To ensure accurate input structures for docking, the three-dimensional structures of the filtered generated sequences and the structures of all docking targets were predicted using AlphaFold3. AlphaFold3 [<xref rid="B39-toxins-17-00093" ref-type="bibr">39</xref>], a deep learning-based protein structure prediction tool, produces high-confidence three-dimensional conformations of sequences.</p><p>The docking targets included five subtypes of nicotinic acetylcholine receptors (nAChRs), specifically &#x003b1;3&#x003b2;2, &#x003b1;3&#x003b2;4, &#x003b1;4&#x003b2;2, &#x003b1;7 and &#x003b1;9&#x003b1;10, along with several specific ion channels. These ion channels comprised calcium ion channels (Ca), including L-type (Ca<sub>v</sub>1.1), P/Q-type (Ca<sub>v</sub>2.1), and N-type (Ca<sub>v</sub>2.2); sodium ion channels, including Na<sub>v</sub>1.2, Na<sub>v</sub>1.3, Na<sub>v</sub>1.4, and Na<sub>v</sub>1.7; and voltage-gated potassium channels (K<sub>v</sub>), such as K<sub>v</sub>1.3 and K<sub>v</sub>2.1. In the experimental design, the selected generated sequences were first subjected to AlphaFold for three-dimensional structure prediction. The resulting structures were optimized and then input into LeDock for docking analysis with the target receptors. Each sequence was docked against multiple receptor subtypes, with binding free energies (measured in kcal/mol) and other related parameters recorded.</p></sec><sec id="sec4dot6-toxins-17-00093"><title>4.6. Molecular Dynamics Simulation</title><p>In this study, molecular dynamics (MDs) simulations were employed to analyze the dynamic behavior of certain peptide&#x02013;target complexes obtained from molecular docking. MDs simulations provide insights into the dynamic behavior of molecules in their natural environment, enabling the evaluation of the stability of peptide&#x02013;target complexes.</p><p>The peptide&#x02013;target complexes derived from the docking results were selected for MDs simulations using Gromacs software (2022.2 version). The Amber99sb-ildn force field was applied to proteins and peptides, and the TIP3P water model was used to solvate the system. A cubic simulation box of size 10 &#x000d7; 10 &#x000d7; 10 nm<sup>3</sup> was constructed, with at least 1.2 nm between the protein and the box edges. The system was neutralized with counterions to maintain overall charge neutrality. Electrostatic interactions were calculated using the Particle Mesh Ewald (PME) method, and energy minimization was performed using the steepest descent algorithm for up to 50,000 steps. The cutoff distances for Coulomb and van der Waals interactions were set to 1 nm.</p><p>After energy minimization, the system was equilibrated under constant volume and temperature (NVT) conditions, followed by constant pressure and temperature (NPT) conditions. The final production run consisted of a 100 ns MDs simulation at 300 K and 1 bar. A cutoff distance of 10 &#x000c5; was used for non-bonded interactions. The Langevin thermostat was applied to maintain a stable temperature, while the Berendsen barostat was used to regulate pressure.</p></sec></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, G.Z., R.Y. and H.L.; methodology, G.Z.; investigation, C.G.; resources, C.G.; formal analysis, W.H.; visualization, W.H.; writing&#x02014;original draft, G.Z. and H.L.; writing&#x02014;review and editing, G.Z. and H.L.; supervision, R.Y. and H.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study were obtained from publicly available databases, ConoServer (<uri xlink:href="http://www.conoserver.org">http://www.conoserver.org</uri>) (accessed on 1 June 2024) and UniProt (<uri xlink:href="https://www.uniprot.org">https://www.uniprot.org</uri>) (accessed on 1 June 2024). Further details regarding data curation and analysis can be obtained from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxins-17-00093"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Conotoxins as Selective Inhibitors of Neuronal Ion Channels, Receptors and Transporters</article-title><source>IUBMB Life</source><year>2004</year><volume>56</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1080/15216540410001668055</pub-id><pub-id pub-id-type="pmid">15085932</pub-id>
</element-citation></ref><ref id="B2-toxins-17-00093"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Akondi</surname><given-names>K.B.</given-names></name>
<name><surname>Muttenthaler</surname><given-names>M.</given-names></name>
<name><surname>Dutertre</surname><given-names>S.</given-names></name>
<name><surname>Kaas</surname><given-names>Q.</given-names></name>
<name><surname>Craik</surname><given-names>D.J.</given-names></name>
<name><surname>Lewis</surname><given-names>R.J.</given-names></name>
<name><surname>Alewood</surname><given-names>P.F.</given-names></name>
</person-group><article-title>Discovery, Synthesis, and Structure- Activity Relationships of Conotoxins</article-title><source>Chem. Rev.</source><year>2014</year><volume>114</volume><fpage>5815</fpage><lpage>5847</lpage><pub-id pub-id-type="doi">10.1021/cr400401e</pub-id><pub-id pub-id-type="pmid">24720541</pub-id>
</element-citation></ref><ref id="B3-toxins-17-00093"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pope</surname><given-names>J.E.</given-names></name>
<name><surname>Deer</surname><given-names>T.R.</given-names></name>
</person-group><article-title>Ziconotide: A Clinical Update and Pharmacologic Review</article-title><source>Expert Opin. Pharmacother.</source><year>2013</year><volume>14</volume><fpage>957</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1517/14656566.2013.784269</pub-id><pub-id pub-id-type="pmid">23537340</pub-id>
</element-citation></ref><ref id="B4-toxins-17-00093"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Dong</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Zhangsun</surname><given-names>D.</given-names></name>
<name><surname>Luo</surname><given-names>S.</given-names></name>
</person-group><article-title>Discovery Methodology of Novel Conotoxins from Conus Species</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>417</elocation-id><pub-id pub-id-type="doi">10.3390/md16110417</pub-id><pub-id pub-id-type="pmid">30380764</pub-id>
</element-citation></ref><ref id="B5-toxins-17-00093"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Ju</surname><given-names>S.</given-names></name>
<name><surname>Ma</surname><given-names>B.</given-names></name>
<name><surname>Huang</surname><given-names>W.</given-names></name>
<name><surname>Luo</surname><given-names>S.</given-names></name>
</person-group><article-title>Isolation and Characterization of Five Novel Disulfide-Poor Conopeptides from Conus marmoreus Venom</article-title><source>J. Venom. Anim. Toxins Incl. Trop. Dis.</source><year>2022</year><volume>28</volume><fpage>e20210116</fpage><pub-id pub-id-type="doi">10.1590/1678-9199-jvatitd-2021-0116</pub-id><pub-id pub-id-type="pmid">35677566</pub-id>
</element-citation></ref><ref id="B6-toxins-17-00093"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>X.</given-names></name>
<name><surname>Hone</surname><given-names>A.J.</given-names></name>
<name><surname>Huang</surname><given-names>Y.H.</given-names></name>
<name><surname>Clark</surname><given-names>R.J.</given-names></name>
<name><surname>McIntosh</surname><given-names>J.M.</given-names></name>
<name><surname>Kaas</surname><given-names>Q.</given-names></name>
<name><surname>Craik</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Computational Design of Alpha-Conotoxins to Target Specific Nicotinic Acetylcholine Receptor Subtypes</article-title><source>Chemistry</source><year>2023</year><volume>30</volume><fpage>e202302909</fpage><pub-id pub-id-type="doi">10.1002/chem.202302909</pub-id><pub-id pub-id-type="pmid">37910861</pub-id>
</element-citation></ref><ref id="B7-toxins-17-00093"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grisoni</surname><given-names>F.</given-names></name>
</person-group><article-title>Chemical Language Models for De Novo Drug Design: Challenges and Opportunities</article-title><source>Curr. Opin. Struct. Biol.</source><year>2023</year><volume>79</volume><elocation-id>102527</elocation-id><pub-id pub-id-type="doi">10.1016/j.sbi.2023.102527</pub-id><pub-id pub-id-type="pmid">36738564</pub-id>
</element-citation></ref><ref id="B8-toxins-17-00093"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strokach</surname><given-names>A.</given-names></name>
<name><surname>Kim</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Deep Generative Modeling for Protein Design</article-title><source>Curr. Opin. Struct. Biol.</source><year>2022</year><volume>72</volume><fpage>226</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2021.11.008</pub-id><pub-id pub-id-type="pmid">34963082</pub-id>
</element-citation></ref><ref id="B9-toxins-17-00093"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Melo</surname><given-names>M.C.</given-names></name>
<name><surname>Maasch</surname><given-names>J.R.</given-names></name>
<name><surname>de la Fuente-Nunez</surname><given-names>C.</given-names></name>
</person-group><article-title>Accelerating Antibiotic Discovery through Artificial Intelligence</article-title><source>Commun. Biol.</source><year>2021</year><volume>4</volume><elocation-id>1050</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-02586-0</pub-id><pub-id pub-id-type="pmid">34504303</pub-id>
</element-citation></ref><ref id="B10-toxins-17-00093"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>C.H.</given-names></name>
<name><surname>Bepler</surname><given-names>T.</given-names></name>
<name><surname>Pepper</surname><given-names>K.</given-names></name>
<name><surname>Fu</surname><given-names>D.</given-names></name>
<name><surname>Lu</surname><given-names>T.K.</given-names></name>
</person-group><article-title>Synthetic Molecular Evolution of Antimicrobial Peptides</article-title><source>Curr. Opin. Biotechnol.</source><year>2022</year><volume>75</volume><elocation-id>102718</elocation-id><pub-id pub-id-type="doi">10.1016/j.copbio.2022.102718</pub-id><pub-id pub-id-type="pmid">35395425</pub-id>
</element-citation></ref><ref id="B11-toxins-17-00093"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fernandes</surname><given-names>F.C.</given-names></name>
<name><surname>Cardoso</surname><given-names>M.H.</given-names></name>
<name><surname>Gil-Ley</surname><given-names>A.</given-names></name>
<name><surname>Luchi</surname><given-names>L.V.</given-names></name>
<name><surname>da Silva</surname><given-names>M.G.L.</given-names></name>
<name><surname>Macedo</surname><given-names>M.L.R.</given-names></name>
<name><surname>de la Fuente-Nunez</surname><given-names>C.</given-names></name>
<name><surname>Franco</surname><given-names>O.L.</given-names></name>
</person-group><article-title>Geometric Deep Learning as a Potential Tool for Antimicrobial Peptide Prediction</article-title><source>Front. Bioinform.</source><year>2023</year><volume>3</volume><elocation-id>1216362</elocation-id><pub-id pub-id-type="doi">10.3389/fbinf.2023.1216362</pub-id><pub-id pub-id-type="pmid">37521317</pub-id>
</element-citation></ref><ref id="B12-toxins-17-00093"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferrell</surname><given-names>J.B.</given-names></name>
<name><surname>Remington</surname><given-names>J.M.</given-names></name>
<name><surname>Van Oort</surname><given-names>C.M.</given-names></name>
<name><surname>Sharafi</surname><given-names>M.</given-names></name>
<name><surname>Aboushousha</surname><given-names>R.</given-names></name>
<name><surname>Janssen-Heininger</surname><given-names>Y.</given-names></name>
<name><surname>Schneebeli</surname><given-names>S.T.</given-names></name>
<name><surname>Wargo</surname><given-names>M.J.</given-names></name>
<name><surname>Wshah</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
</person-group><article-title>A Generative Approach Toward Precision Antimicrobial Peptide Design</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.10.02.324087</pub-id></element-citation></ref><ref id="B13-toxins-17-00093"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Oort</surname><given-names>C.M.</given-names></name>
<name><surname>Ferrell</surname><given-names>J.B.</given-names></name>
<name><surname>Remington</surname><given-names>J.M.</given-names></name>
<name><surname>Wshah</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
</person-group><article-title>AMPGAN v2: Machine Learning-Guided Design of Antimicrobial Peptides</article-title><source>J. Chem. Inf. Model.</source><year>2021</year><volume>61</volume><fpage>2198</fpage><lpage>2207</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.0c01441</pub-id><pub-id pub-id-type="pmid">33787250</pub-id>
</element-citation></ref><ref id="B14-toxins-17-00093"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>Q.</given-names></name>
<name><surname>Ge</surname><given-names>C.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Harvey</surname><given-names>P.J.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Ma</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Jia</surname><given-names>X.</given-names></name>
<name><surname>Mobli</surname><given-names>M.</given-names></name>
<name><surname>Craik</surname><given-names>D.J.</given-names></name>
<etal/>
</person-group><article-title>Designing Antimicrobial Peptides Using Deep Learning and Molecular Dynamic Simulations</article-title><source>Brief. Bioinform.</source><year>2023</year><volume>24</volume><elocation-id>bbad058</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbad058</pub-id><pub-id pub-id-type="pmid">36857616</pub-id>
</element-citation></ref><ref id="B15-toxins-17-00093"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pandi</surname><given-names>A.</given-names></name>
<name><surname>Adam</surname><given-names>D.</given-names></name>
<name><surname>Zare</surname><given-names>A.</given-names></name>
<name><surname>Trinh</surname><given-names>V.T.</given-names></name>
<name><surname>Schaefer</surname><given-names>S.L.</given-names></name>
<name><surname>Burt</surname><given-names>M.</given-names></name>
<name><surname>Klabunde</surname><given-names>B.</given-names></name>
<name><surname>Bobkova</surname><given-names>E.</given-names></name>
<name><surname>Kushwaha</surname><given-names>M.</given-names></name>
<name><surname>Foroughijabbari</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Cell-Free Biosynthesis Combined with Deep Learning Accelerates De Novo Development of Antimicrobial Peptides</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>7197</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-42434-9</pub-id><pub-id pub-id-type="pmid">37938588</pub-id>
</element-citation></ref><ref id="B16-toxins-17-00093"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Renaud</surname><given-names>S.</given-names></name>
<name><surname>Mansbach</surname><given-names>R.A.</given-names></name>
</person-group><article-title>Latent Spaces for Antimicrobial Peptide Design</article-title><source>Dig. Discov.</source><year>2023</year><volume>2</volume><fpage>441</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1039/D2DD00091A</pub-id></element-citation></ref><ref id="B17-toxins-17-00093"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoffman</surname><given-names>S.C.</given-names></name>
<name><surname>Chenthamarakshan</surname><given-names>V.</given-names></name>
<name><surname>Wadhawan</surname><given-names>K.</given-names></name>
<name><surname>Chen</surname><given-names>P.-Y.</given-names></name>
<name><surname>Das</surname><given-names>P.</given-names></name>
</person-group><article-title>Optimizing Molecules Using Efficient Queries from Property Evaluations</article-title><source>Nat. Mach. Intell.</source><year>2022</year><volume>4</volume><fpage>21</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/s42256-021-00422-y</pub-id></element-citation></ref><ref id="B18-toxins-17-00093"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>T.</given-names></name>
<name><surname>Vure</surname><given-names>P.</given-names></name>
<name><surname>Pulugurta</surname><given-names>R.</given-names></name>
<name><surname>Chatterjee</surname><given-names>P.</given-names></name>
</person-group><article-title>AMP-Diffusion: Integrating Latent Diffusion with Protein Language Models for Antimicrobial Peptide Generation</article-title><source>bioRxiv</source><year>2024</year><pub-id pub-id-type="doi">10.1101/2024.03.03.583201</pub-id></element-citation></ref><ref id="B19-toxins-17-00093"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Szymczak</surname><given-names>P.</given-names></name>
<name><surname>Mo&#x0017c;ejko</surname><given-names>M.</given-names></name>
<name><surname>Grzegorzek</surname><given-names>T.</given-names></name>
<name><surname>Jurczak</surname><given-names>R.</given-names></name>
<name><surname>Bauer</surname><given-names>M.</given-names></name>
<name><surname>Neubauer</surname><given-names>D.</given-names></name>
<name><surname>Sikora</surname><given-names>K.</given-names></name>
<name><surname>Michalski</surname><given-names>M.</given-names></name>
<name><surname>Sroka</surname><given-names>J.</given-names></name>
<name><surname>Setny</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Discovering Highly Potent Antimicrobial Peptides with Deep Generative Model HydrAMP</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>1453</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-36994-z</pub-id><pub-id pub-id-type="pmid">36922490</pub-id>
</element-citation></ref><ref id="B20-toxins-17-00093"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madani</surname><given-names>A.</given-names></name>
<name><surname>Krause</surname><given-names>B.</given-names></name>
<name><surname>Greene</surname><given-names>E.R.</given-names></name>
<name><surname>Subramanian</surname><given-names>S.</given-names></name>
<name><surname>Mohr</surname><given-names>B.P.</given-names></name>
<name><surname>Holton</surname><given-names>J.M.</given-names></name>
<name><surname>Olmos</surname><given-names>J.L.</given-names><suffix>Jr.</suffix></name>
<name><surname>Xiong</surname><given-names>C.</given-names></name>
<name><surname>Sun</surname><given-names>Z.Z.</given-names></name>
<name><surname>Socher</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Large Language Models Generate Functional Protein Sequences across Diverse Families</article-title><source>Nat. Biotechnol.</source><year>2023</year><volume>41</volume><fpage>1099</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1038/s41587-022-01618-2</pub-id><pub-id pub-id-type="pmid">36702895</pub-id>
</element-citation></ref><ref id="B21-toxins-17-00093"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferruz</surname><given-names>N.</given-names></name>
<name><surname>Schmidt</surname><given-names>S.</given-names></name>
<name><surname>H&#x000f6;cker</surname><given-names>B.</given-names></name>
</person-group><article-title>ProtGPT2 Is a Deep Unsupervised Language Model for Protein Design</article-title><source>Nat. Commun.</source><year>2022</year><volume>13</volume><fpage>4348</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-32007-7</pub-id><pub-id pub-id-type="pmid">35896542</pub-id>
</element-citation></ref><ref id="B22-toxins-17-00093"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Bhatnagar</surname><given-names>A.</given-names></name>
<name><surname>Ruffolo</surname><given-names>J.A.</given-names></name>
<name><surname>Madani</surname><given-names>A.</given-names></name>
</person-group><article-title>Conditional Enzyme Generation Using Protein Language Models with Adapters</article-title><source>arXiv</source><year>2024</year><pub-id pub-id-type="arxiv">2410.03634</pub-id></element-citation></ref><ref id="B23-toxins-17-00093"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shrestha</surname><given-names>P.</given-names></name>
<name><surname>Kandel</surname><given-names>J.</given-names></name>
<name><surname>Tayara</surname><given-names>H.</given-names></name>
<name><surname>Chong</surname><given-names>K.T.</given-names></name>
</person-group><article-title>Post-Translational Modification Prediction via Prompt-Based Fine-Tuning of a GPT-2 Model</article-title><source>Nat. Commun.</source><year>2024</year><volume>15</volume><fpage>6699</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-51071-9</pub-id><pub-id pub-id-type="pmid">39107330</pub-id>
</element-citation></ref><ref id="B24-toxins-17-00093"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olivera</surname><given-names>B.M.</given-names></name>
</person-group><article-title>Conus Peptides: Biodiversity-Based Discovery and Exogenomics</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>31173</fpage><lpage>31177</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)84029-2</pub-id><pub-id pub-id-type="pmid">16905531</pub-id>
</element-citation></ref><ref id="B25-toxins-17-00093"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaas</surname><given-names>Q.</given-names></name>
<name><surname>Yu</surname><given-names>R.</given-names></name>
<name><surname>Jin</surname><given-names>A.-H.</given-names></name>
<name><surname>Dutertre</surname><given-names>S.</given-names></name>
<name><surname>Craik</surname><given-names>D.J.</given-names></name>
</person-group><article-title>ConoServer: Updated Content, Knowledge, and Discovery Tools in the Conopeptide Database</article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>40</volume><fpage>D325</fpage><lpage>D330</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr886</pub-id><pub-id pub-id-type="pmid">22058133</pub-id>
</element-citation></ref><ref id="B26-toxins-17-00093"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buczek</surname><given-names>O.</given-names></name>
<name><surname>Bulaj</surname><given-names>G.</given-names></name>
<name><surname>Olivera</surname><given-names>B.M.</given-names></name>
</person-group><article-title>Conotoxins and the Posttranslational Modification of Secreted Gene Products</article-title><source>Cell. Mol. Life Sci.</source><year>2005</year><volume>62</volume><fpage>3067</fpage><lpage>3079</lpage><pub-id pub-id-type="doi">10.1007/s00018-005-5283-0</pub-id><pub-id pub-id-type="pmid">16314929</pub-id>
</element-citation></ref><ref id="B27-toxins-17-00093"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shannon</surname><given-names>C.E.</given-names></name>
</person-group><article-title>A Mathematical Theory of Communication</article-title><source>Bell Syst. Tech. J.</source><year>1948</year><volume>27</volume><fpage>379</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1002/j.1538-7305.1948.tb01338.x</pub-id></element-citation></ref><ref id="B28-toxins-17-00093"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Styczynski</surname><given-names>M.P.</given-names></name>
<name><surname>Jensen</surname><given-names>K.L.</given-names></name>
<name><surname>Rigoutsos</surname><given-names>I.</given-names></name>
<name><surname>Stephanopoulos</surname><given-names>G.</given-names></name>
</person-group><article-title>BLOSUM62 Miscalculations Improve Search Performance</article-title><source>Nat. Biotechnol.</source><year>2008</year><volume>26</volume><fpage>274</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1038/nbt0308-274</pub-id><pub-id pub-id-type="pmid">18327232</pub-id>
</element-citation></ref><ref id="B29-toxins-17-00093"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Du</surname><given-names>Z.</given-names></name>
<name><surname>Ding</surname><given-names>X.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
</person-group><article-title>UniDL4BioPep: A Universal Deep Learning Architecture for Binary Classification in Peptide Bioactivity</article-title><source>Brief. Bioinform.</source><year>2023</year><volume>24</volume><elocation-id>bbad135</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbad135</pub-id><pub-id pub-id-type="pmid">37020337</pub-id>
</element-citation></ref><ref id="B30-toxins-17-00093"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McInnes</surname><given-names>L.</given-names></name>
<name><surname>Healy</surname><given-names>J.</given-names></name>
<name><surname>Melville</surname><given-names>J.</given-names></name>
</person-group><article-title>UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction</article-title><source>arXiv</source><year>2018</year><pub-id pub-id-type="arxiv">1802.03426</pub-id></element-citation></ref><ref id="B31-toxins-17-00093"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cordoves-Delgado</surname><given-names>G.</given-names></name>
<name><surname>Garc&#x000ed;a-Jacas</surname><given-names>C.R.</given-names></name>
</person-group><article-title>Predicting Antimicrobial Peptides Using ESMFold-Predicted Structures and ESM-2-Based Amino Acid Features with Graph Deep Learning</article-title><source>J. Chem. Inf. Model.</source><year>2024</year><volume>64</volume><fpage>4310</fpage><lpage>4321</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.3c02061</pub-id><pub-id pub-id-type="pmid">38739853</pub-id>
</element-citation></ref><ref id="B32-toxins-17-00093"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shah</surname><given-names>A.</given-names></name>
<name><surname>Guntuboina</surname><given-names>C.</given-names></name>
<name><surname>Farimani</surname><given-names>A.B.</given-names></name>
</person-group><article-title>Peptide-GPT: Generative Design of Peptides Using Generative Pre-Trained Transformers and Bio-Informatic Supervision</article-title><source>arXiv</source><year>2024</year><pub-id pub-id-type="arxiv">2410.19222</pub-id></element-citation></ref><ref id="B33-toxins-17-00093"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Xu</surname><given-names>Z.</given-names></name>
</person-group><article-title>Using LeDock as a Docking Tool for Computational Drug Design</article-title><source>IOP Conf. Ser. Earth Environ. Sci.</source><year>2019</year><volume>218</volume><fpage>012149</fpage><pub-id pub-id-type="doi">10.1088/1755-1315/218/1/012143</pub-id></element-citation></ref><ref id="B34-toxins-17-00093"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaas</surname><given-names>Q.</given-names></name>
<name><surname>Westermann</surname><given-names>J.-C.</given-names></name>
<name><surname>Craik</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Conopeptide Characterization and Classifications: An Analysis Using ConoServer</article-title><source>Toxicon</source><year>2010</year><volume>55</volume><fpage>1491</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2010.03.002</pub-id><pub-id pub-id-type="pmid">20211197</pub-id>
</element-citation></ref><ref id="B35-toxins-17-00093"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>W.</given-names></name>
<name><surname>Caffrey</surname><given-names>M.</given-names></name>
</person-group><article-title>Interactions of tryptophan, tryptophan peptides, and tryptophan alkyl esters at curved membrane interfaces</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>11713</fpage><lpage>11726</lpage><pub-id pub-id-type="doi">10.1021/bi0608414</pub-id><pub-id pub-id-type="pmid">17002272</pub-id>
</element-citation></ref><ref id="B36-toxins-17-00093"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khemaissa</surname><given-names>S.</given-names></name>
<name><surname>Sagan</surname><given-names>S.</given-names></name>
<name><surname>Walrant</surname><given-names>A.</given-names></name>
</person-group><article-title>Tryptophan, an Amino-Acid Endowed with Unique Properties and Its Many Roles in Membrane Proteins</article-title><source>Crystals</source><year>2021</year><volume>11</volume><elocation-id>1032</elocation-id><pub-id pub-id-type="doi">10.3390/cryst11091032</pub-id></element-citation></ref><ref id="B37-toxins-17-00093"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wen</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Liao</surname><given-names>J.</given-names></name>
<name><surname>Zheng</surname><given-names>X.</given-names></name>
<name><surname>Yin</surname><given-names>Z.</given-names></name>
</person-group><article-title>Preferential interactions between protein and arginine: Effects of arginine on tertiary conformational and colloidal stability of protein solution</article-title><source>Int. J. Pharm.</source><year>2015</year><volume>478</volume><fpage>753</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2014.12.038</pub-id><pub-id pub-id-type="pmid">25529432</pub-id>
</element-citation></ref><ref id="B38-toxins-17-00093"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>UniProt Consortium</collab>
</person-group><article-title>UniProt: A Hub for Protein Information</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>D204</fpage><lpage>D212</lpage><pub-id pub-id-type="doi">10.1093/nar/gku989</pub-id><pub-id pub-id-type="pmid">25348405</pub-id>
</element-citation></ref><ref id="B39-toxins-17-00093"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abramson</surname><given-names>J.</given-names></name>
<name><surname>Adler</surname><given-names>J.</given-names></name>
<name><surname>Dunger</surname><given-names>J.</given-names></name>
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Green</surname><given-names>T.</given-names></name>
<name><surname>Pritzel</surname><given-names>A.</given-names></name>
<name><surname>Ronneberger</surname><given-names>O.</given-names></name>
<name><surname>Willmore</surname><given-names>L.</given-names></name>
<name><surname>Ballard</surname><given-names>A.J.</given-names></name>
<name><surname>Bambrick</surname><given-names>J.</given-names></name>
</person-group><article-title>Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3</article-title><source>Nature</source><year>2024</year><volume>630</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07487-w</pub-id><pub-id pub-id-type="pmid">38718835</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxins-17-00093-f001"><label>Figure 1</label><caption><p>Comparison of amino acid composition and physicochemical properties between sequences generated by the ConoGPT model and real conotoxins. (<bold>a</bold>) Amino acid composition shows a high degree of similarity, particularly in the proportions of cysteine, glutamic acid, and aspartic acid. (<bold>b</bold>) Charge distributions of generated and real sequences are highly overlapping, with most sequences having a charge between 0 and +3. (<bold>c</bold>) Isoelectric point (pI) analysis indicates similar distributions across the range of 4&#x02013;10, with peaks around 6&#x02013;8. (<bold>d</bold>) Hydrophobicity profiles of generated and real sequences are centered near zero, indicating comparable properties critical for conotoxin stability and function.</p></caption><graphic xlink:href="toxins-17-00093-g001a" position="float"/><graphic xlink:href="toxins-17-00093-g001b" position="float"/></fig><fig position="float" id="toxins-17-00093-f002"><label>Figure 2</label><caption><p>Shannon&#x02019;s entropy divergence between the distributions of length 2 (<bold>left</bold>) and length 3 (<bold>right</bold>) subsequences of FASTA characters in conotoxins from the training set (real) or conotoxins created by the generator (generated). Blue bars indicate a greater prevalence of a particular subsequence in real conotoxins, while gold bars indicate a greater prevalence in generated conotoxins. For length 2 subsequences, the average entropy was 7.94 for real sequences and 7.79 for generated sequences, while for length 3 subsequences, the average entropy was 11.42 for real sequences and 11.38 for generated sequences. For reference, the distribution of subsequences drawn from uniformly random sequences results in a maximum entropy of ~8.64 for length 2 subsequences and &#x0223c;12.97 for length 3 subsequences. Both groups in both plots feature a lower entropy than the maximum; thus, we should expect to see meaningful structures in each group.</p></caption><graphic xlink:href="toxins-17-00093-g002" position="float"/></fig><fig position="float" id="toxins-17-00093-f003"><label>Figure 3</label><caption><p>Cysteine framework distributions in generated and real conotoxin sequences. The cysteine connectivity is not known for all frameworks; only frameworks I, IV, V, VI/VII, IX, X, XI, and XIV have confirmed connectivity.</p></caption><graphic xlink:href="toxins-17-00093-g003" position="float"/></fig><fig position="float" id="toxins-17-00093-f004"><label>Figure 4</label><caption><p>Distribution of sequence match scores across three groups: &#x0201c;Real vs. Self&#x0201d;, &#x0201c;Generated vs. Self&#x0201d;, and &#x0201c;Generated vs. Real&#x0201d;. The &#x0201c;Real vs. Self&#x0201d; group displays a higher median score with a concentrated distribution, while the &#x0201c;Generated vs. Self&#x0201d; group shows greater variability and diversity. The &#x0201c;Generated vs. Real&#x0201d; group demonstrates the lowest median score, emphasizing the novelty of generated sequences compared to real conotoxins.</p></caption><graphic xlink:href="toxins-17-00093-g004" position="float"/></fig><fig position="float" id="toxins-17-00093-f005"><label>Figure 5</label><caption><p>UMAP visualization of the embedding space for generated sequences (mint green) and real sequences, with active real sequences shown in red and inactive real sequences shown in blue. The magnified view highlights the overlap between generated sequences and active real sequences, demonstrating the ability of the model to generate sequences closely resembling real active ones while also exploring new regions of the embedding space.</p></caption><graphic xlink:href="toxins-17-00093-g005" position="float"/></fig><fig position="float" id="toxins-17-00093-f006"><label>Figure 6</label><caption><p>Density comparison of perplexity distributions for sequences generated by the baseline model (red) and the improved model (blue). The improved model demonstrates slightly lower average perplexity compared to the baseline model.</p></caption><graphic xlink:href="toxins-17-00093-g006" position="float"/></fig><fig position="float" id="toxins-17-00093-f007"><label>Figure 7</label><caption><p>Box plot comparison of pLDDT distributions for sequences generated by the baseline model and the improved model.</p></caption><graphic xlink:href="toxins-17-00093-g007" position="float"/></fig><fig position="float" id="toxins-17-00093-f008"><label>Figure 8</label><caption><p>Cysteine framework distribution generated by the improved model (blue) and the baseline model (pink). The improved model demonstrates a higher proportion in the vast majority of known cysteine-connected frameworks (I, V, VI/VII, IX, X, XI, XIV, as mentioned in <xref rid="sec4dot1-toxins-17-00093" ref-type="sec">Section 4.1</xref>).</p></caption><graphic xlink:href="toxins-17-00093-g008" position="float"/></fig><fig position="float" id="toxins-17-00093-f009"><label>Figure 9</label><caption><p>(<bold>a</bold>) Molecular docking result of the generated sequence YRRECCSNPACRVDHPEICG with the &#x003b1;9&#x003b1;10 subtype of nAChR. (<bold>b</bold>) Molecular docking result of the real conotoxin GI with the &#x003b1;9&#x003b1;10 subtype of nAChR, showing binding interactions with the same target as in (<bold>a</bold>). (<bold>c</bold>) Docking result of the generated sequence CKGKGAKCSLTSSNCCSGSCRSGKC with a calcium ion channel. (<bold>d</bold>) Docking result of the real conotoxin CVIA with a calcium ion channel, comparing the binding affinity and interaction sites with the same target as in (<bold>c</bold>).</p></caption><graphic xlink:href="toxins-17-00093-g009" position="float"/></fig><fig position="float" id="toxins-17-00093-f010"><label>Figure 10</label><caption><p>Molecular dynamics simulation of the generated sequence GCCADPKCAFNNPELC with the &#x003b1;3&#x003b2;4 subtype of nAChR. (<bold>a</bold>) The radius of gyration (Rg) values. (<bold>b</bold>) The root-mean-square deviation (RMSD) over time. (<bold>c</bold>) The binding free energy analysis. (<bold>d</bold>) The residue interaction analysis.</p></caption><graphic xlink:href="toxins-17-00093-g010a" position="float"/><graphic xlink:href="toxins-17-00093-g010b" position="float"/></fig><table-wrap position="float" id="toxins-17-00093-t001"><object-id pub-id-type="pii">toxins-17-00093-t001_Table 1</object-id><label>Table 1</label><caption><p>Proportion of high-confidence sequences (pLDDT &#x0003e; 0.7) generated by the baseline and improved models.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage with pLDDT &#x0003e; 0.7 (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean pLDDT</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Improve</td><td align="center" valign="middle" rowspan="1" colspan="1">21.08 &#x000b1; 0.56</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6090 &#x000b1; 0.0033</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseline</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.52 &#x000b1; 1.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5820 &#x000b1; 0.0019</td></tr></tbody></table></table-wrap><table-wrap position="float" id="toxins-17-00093-t002"><object-id pub-id-type="pii">toxins-17-00093-t002_Table 2</object-id><label>Table 2</label><caption><p>Distribution of docking results across receptor targets for the 191 generated sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Sequences</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Proportion (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">nAChR</td><td align="center" valign="middle" rowspan="1" colspan="1">173</td><td align="center" valign="middle" rowspan="1" colspan="1">90.57</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Na</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.52</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ca</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">1.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.85</td></tr></tbody></table></table-wrap><table-wrap position="float" id="toxins-17-00093-t003"><object-id pub-id-type="pii">toxins-17-00093-t003_Table 3</object-id><label>Table 3</label><caption><p>Distribution of cysteine frameworks with known disulfide bond connectivity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Framework</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cysteine Pattern</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cysteines</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Connectivity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">I</td><td align="center" valign="middle" rowspan="1" colspan="1">CC-C-C</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">I&#x02013;III, II&#x02013;IV</td><td align="center" valign="middle" rowspan="1" colspan="1">28.95</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">IV</td><td align="center" valign="middle" rowspan="1" colspan="1">CC-C-C-C-C</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">I&#x02013;V, II&#x02013;III, IV&#x02013;VI</td><td align="center" valign="middle" rowspan="1" colspan="1">2.50</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">V</td><td align="center" valign="middle" rowspan="1" colspan="1">CC-CC</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">I&#x02013;III, II&#x02013;IV</td><td align="center" valign="middle" rowspan="1" colspan="1">6.59</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">VI/VII</td><td align="center" valign="middle" rowspan="1" colspan="1">C-C-CC-C-C</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">I&#x02013;IV, II&#x02013;V, III&#x02013;VI</td><td align="center" valign="middle" rowspan="1" colspan="1">26.27</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">IX</td><td align="center" valign="middle" rowspan="1" colspan="1">C-C-C-C-C-C</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">I&#x02013;IV, II&#x02013;V, III&#x02013;VI</td><td align="center" valign="middle" rowspan="1" colspan="1">1.09</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">X</td><td align="center" valign="middle" rowspan="1" colspan="1">CC-C.[PO]C</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">I&#x02013;IV, II&#x02013;III</td><td align="center" valign="middle" rowspan="1" colspan="1">2.33</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">XI</td><td align="center" valign="middle" rowspan="1" colspan="1">C-C-CC-CC-C-C</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">I&#x02013;IV, II&#x02013;VI, III&#x02013;VII, V&#x02013;VIII</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XIV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C-C-C-C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I&#x02013;III, II&#x02013;IV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.71</td></tr></tbody></table></table-wrap><table-wrap position="float" id="toxins-17-00093-t004"><object-id pub-id-type="pii">toxins-17-00093-t004_Table 4</object-id><label>Table 4</label><caption><p>Performance metrics of the retrained UniDL4BioPep model for conotoxin activity prediction.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Metric</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Accuracy (ACC)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.959</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Balanced accuracy (BACC)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.955</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sensitivity (Sn)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.969</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Specificity (Sp)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.942</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Matthews correlation coefficient (MCC)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.911</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Area under the curve (AUC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.991</td></tr></tbody></table></table-wrap></floats-group></article>